Purpura of the Face and Neck: An Atypical Clinical Presentation Revealing a Hepatosplenic T Cell Lymphoma
Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis and worsens the prognosis of patient survival. Efforts should be aimed at early recognition and treatment. Methods:...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2014-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_40a7d2d9d31044c8bb37008c1a937f9f | ||
042 | |a dc | ||
100 | 1 | 0 | |a François Kuonen |e author |
700 | 1 | 0 | |a Maya Bucher |e author |
700 | 1 | 0 | |a Laurence de Leval |e author |
700 | 1 | 0 | |a Maxime Vernez |e author |
700 | 1 | 0 | |a Michel Gilliet |e author |
700 | 1 | 0 | |a Curdin Conrad |e author |
700 | 1 | 0 | |a Laurence Feldmeyer |e author |
245 | 0 | 0 | |a Purpura of the Face and Neck: An Atypical Clinical Presentation Revealing a Hepatosplenic T Cell Lymphoma |
260 | |b Karger Publishers, |c 2014-02-01T00:00:00Z. | ||
500 | |a 1662-6567 | ||
500 | |a 10.1159/000360126 | ||
520 | |a Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis and worsens the prognosis of patient survival. Efforts should be aimed at early recognition and treatment. Methods: We describe a case of a 62-year-old woman who presented at our clinic with a non-palpable purpuric eruption of the face. Investigations revealed thrombocytopenia with hepatosplenomegaly, which showed rapid progression together with accentuation of the purpura. Two months later, a bone marrow biopsy revealed the diagnosis of a HSTL. Results: The patient received six cycles of CHOP chemotherapy (vincristine, cyclophosphamide, doxorubicin, methylprednisolone) followed by a well-tolerated autologous bone marrow graft. Normalization of the platelet count resulted in regression of the purpuric rash. Conclusion: To our knowledge, this is the first report of a facial thrombocytopenic purpura as the inaugural symptom of HSTL. It emphasizes the privileged position of the dermatologist for early recognition of potentially lethal HSTL. | ||
546 | |a EN | ||
690 | |a Purpura | ||
690 | |a Lymphoma | ||
690 | |a Sun exposure | ||
690 | |a Face | ||
690 | |a Dermatology | ||
690 | |a RL1-803 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Case Reports in Dermatology, Vol 6, Iss 1, Pp 37-42 (2014) | |
787 | 0 | |n http://www.karger.com/Article/FullText/360126 | |
787 | 0 | |n https://doaj.org/toc/1662-6567 | |
856 | 4 | 1 | |u https://doaj.org/article/40a7d2d9d31044c8bb37008c1a937f9f |z Connect to this object online. |